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Conserved role of Ovo in germline 
development in mouse and 
Drosophila
Makoto Hayashi1,2,*, Yuko Shinozuka1,*, Shuji Shigenobu3, Masanao Sato4, 
Michihiko Sugimoto5,†, Seiji Ito6, Kuniya Abe2,5 & Satoru Kobayashi1,2
Ovo, which encodes a transcription factor with Zn-finger domains, is evolutionarily conserved among 
animals. In Drosophila, in addition to its zygotic function for egg production, maternal ovo activity is 
required in primordial germ cells (PGCs) for expression of germline genes such as vasa and nanos. In 
this study, we found that maternal Ovo accumulates in PGC nuclei during embryogenesis. In these 
cells, ovo serves a dual function: activation of genes expressed predominantly in PGCs, and conversely 
suppression of somatic genes. Reduction of ovo activity in PGCs makes them unable to develop 
normally into germ cells of both sexes. In mice, knockout of the ovo ortholog, Ovol2, which is expressed 
in PGCs, decreases the number of PGCs during early embryogenesis. These data strongly suggest that 
ovo acts as part of an evolutionarily conserved mechanism that regulates germline development in 
animals.
The germline is the only cell lineage destined to produce the next generation, while the soma gives rise to the 
body tissues. In animals, two distinct modes of germline establishment have been reported, “preformation” and 
“epigenesis“1,2. In the animal species with the preformation mode of germline establishment, maternal factors 
directing germline fate are localized in a specialized ooplasm, or germ plasm, that is partitioned into primordial 
germ cells (PGCs)3. By contrast, in certain species with the epigenesis mode, PGCs are specified by inductive 
signals secreted from the surrounding tissues. For example, in mice, bone morphogenetic proteins (BMPs) and 
Wnt signaling are both essential for PGC induction in the epiblast4–7. Irrespective of the modes of the germline 
establishment, zygotic expression of vasa (vas), nanos (nos), and piwi is evident in the PGCs of a variety of animal 
groups1,8. Therefore, it is possible that the mechanism underlying the activation of germline genes is conserved 
throughout the animal species.
To elucidate how germline gene expression is activated in PGCs, we have identified the pertinent maternal tran-
scription factors in Drosophila, which uses the preformation mode of germline formation9. In this species, the germ 
plasm is localized in the posterior pole of cleavage embryos (stage 1–2) and is subsequently partitioned into PGCs, 
also called pole cells (stage 3–4). PGCs pass through the midgut epithelium to associate with the somatic com-
ponents of the gonads (stage 9–12), and then aggregate with each other to form the embryonic gonads (stage 14). 
Following embryonic development, PGCs differentiate into germ cells (i.e., mature oocytes or sperm) within 
the gonads. Expression of vas begins in PGCs at around stage 9, and continues in germline cells10,11. By contrast, 
piwi and nos transcripts are both maternally supplied in PGCs, and their zygotic expression is evident in PGCs 
around stage 159 (BDGP: http://www.fruitfly.org). The germline-specific expression of these genes is thought 
to be activated by maternal factors localized in the germ plasm. Accordingly, we identified maternal mRNAs 
that are enriched in the germ plasm and encode transcription factors9, and then performed RNA interference 
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(RNAi)-dependent knockdown experiments in order to determine their contribution to germline-specific vas 
and nos expression in PGCs. The results revealed six transcripts required for vas and/or nos gene expression9.
Ovo, one of these six maternal transcripts, belongs to a family of genes encoding DNA-binding proteins with 
C2H2 zinc-finger domains9,12. Ovo is evolutionarily conserved across a wide range of animals13. In Drosophila, ovo 
produces three alternate isoforms: Ovo-A and Ovo-B function as a negative and positive transcriptional regu-
lator in the germline during oogenesis, respectively14, whereas Svb is required for epidermal differentiation15,16. 
During oogenesis, Ovo-B activates transcription of ovo itself and ovarian tumor (otu) by binding their promoter 
regions, and this transcriptional activation is required for production of mature oocytes17,18. Thus, in the absence 
of zygotic ovo activity, female adults never produce progeny; consequently, genetic approaches have failed to clar-
ify the role of maternal ovo in progeny. To overcome this problem, ovo-targeting dsRNA was injected into early 
embryos; however, this approach caused embryonic lethality due to the lack of epidermal differentiation, which 
also requires zygotic ovo function9. Thus, it remains unclear whether maternal ovo function is required for the 
normal development of the germline.
Irrespective of the two modes of germline formation, ovo orthologs are widely conserved among animal spe-
cies13. For example, three ovo orthologs have been identified in the mouse nuclear genome13. The zinc-finger 
domains of Ovol1, Ovol2/MOVO, and Ovol3 share 74%, 68%, and 58% amino-acid identity, respectively, with 
Drosophila ovo19,20. Previous work demonstrated that Ovol2 only partially rescues the defect in Drosophila oogen-
esis caused by ovo mutation20, suggesting that the ovo gene family may exert similar functions in the germline in 
different animal species. However, the role of ovo orthologs in germline development in mouse embryos remains 
unclear.
Here we show that, in Drosophila, maternal Ovo-B protein is predominantly expressed in PGC nuclei. Its 
function is required in PGCs to activate the gene expression highly enriched in the germline, and conversely to 
suppress the somatic genes. Furthermore, Ovo-B must be intact for proper development of the germline both in 
females and males. Moreover, in mice, ovol2 is zygotically expressed in PGCs, and its knockdown decreases the 
number of PGCs at early embryogenesis. Therefore, we propose that ovo plays an evolutionarily conserved role in 
the regulation of germline development in both the fruit fly and mouse.
Results and Discussion
Ovo-B is the major isoform in PGCs of Drosophila embryos. The ovo locus encodes three proteins, 
Ovo-A, Ovo-B, and Svb, which share a common C-terminal region containing Zn-finger DNA-binding domains 
(Fig. 1a). The signal detected by common probes for the three transcripts encoding Ovo-A, Ovo-B, and Svb is 
distributed almost uniformly in cleavage and syncytial blastodermal embryos from stage 2 to stage 4 (Fig. 1b). 
Subsequently, the signal decreases in the somatic region and is enriched in PGCs of the cellular blastodermal 
embryos at stage 5 (Fig. 1b). The signal remains detectable in PGCs until the end of embryogenesis (Fig. 1b,c). 
This spatio-temporal expression of ovo RNA is compatible with observations reported previously9,21,22. To deter-
mine which isoform is expressed in PGCs, we performed whole-mount in situ hybridization (WISH) and quan-
titative RT-PCR (qRT-PCR). WISH analysis using an svb-specific probe detected signal in the epidermis, but not 
in early embryos or PGCs (Fig. 1d,e). This observation strongly suggests that the ovo-A and/or ovo-B transcripts, 
but not svb, are present in PGCs. However, we could not confirm this by WISH using probes specific to ovo-A 
and ovo-B, presumably because the probes were too short (127 and 78 bases, respectively) to detect signals in 
embryos. qRT-PCR analysis detected both ovo-A and ovo-B transcripts in PGCs (Fig. 1f). In these experiments, 
we generated cDNA pools from PGCs of embryos at 11 different stages23,24, and amplified cDNAs using primer 
sets specific to ovo-A and ovo-B (Fig. 1a) (see Supplementary Materials and Methods). We detected ovo-B tran-
script in PGCs throughout the embryonic stages. Expression levels of ovo-B remained constant from stage 4 to 
stage 11, but decreased from stage 12 and thereafter to approximately 10% of peak levels at stage 17. By contrast, 
the level of ovo-A transcript was less than 5% of that of ovo-B throughout the embryonic stages. Thus, ovo-B is the 
major isoform of ovo transcripts in PGCs.
Next, we examined the expression of Ovo protein in PGCs. Because we were unable to raise an antibody 
against Ovo protein, we inserted a tag sequence encoding an enhanced green fluorescent protein (EGFP) into 
the N-terminus of the Ovo-B coding region (ovoB-Nterm-egfp) (Fig. 1a), enabling us to detect Ovo-B protein 
using an anti-GFP antibody. Knock-in of GFP at this site produced a GFP fusion of Ovo-A and Svb as well as 
Ovo-B. Given that ovo-B is the major isoform of ovo transcript in PGCs, it is reasonable to assume that the vast 
majority of the GFP signal detected in PGCs represents Ovo-B expression. This idea is further supported by our 
observation that GFP fused to the Ovo-A–specific region was undetectable in PGCs throughout embryogenesis 
(Supplementary Fig. S1).
In embryos produced from females homozygous for ovoB-Nterm-egfp, the GFP signal was ubiquitously dis-
tributed throughout embryos at stage 2 (Fig. 1g). Subsequently, the signal started to accumulate in nuclei of PGCs 
after stage 4, and this accumulation was maintained in the nuclei of PGCs until at least stage 16 (Fig. 1h–j). By 
contrast, the GFP signal was decreased in the soma, and barely detectable in their nuclei except for a subset of 
epidermal cells, where Svb was zygotically expressed from stage 12 onward16 (Fig. 1j).
The ovo-B transcript is supplied maternally to PGCs, and its levels decreased during embryogenesis (Fig. 1f), 
suggesting that zygotically expressed ovo-B transcript makes little, if any, contribution to the production of 
Ovo protein in PGCs. To confirm this, we examined zygotic expression of GFP in PGCs from the paternally 
transmitted ovoB-Nterm-egfp allele, which produced only a very weak GFP signal in female PGCs after stage 
14 (Fig. 1o–r). This expression pattern is compatible with the previous finding that zygotic ovo expression is 
detectable in PGCs at stage 17 in a female specific manner25. By contrast, GFP expression from the maternal 
ovoB-Nterm-egfp allele was detectable in PGCs from stage 4 until at least stage 16 (Fig. 1k–n). Taken together, our 
observations show that Ovo-B protein produced from the maternal ovo-B transcript is dominant in PGCs during 
embryogenesis.
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Figure 1. Structure of the ovo gene and its expression during embryogenesis. (a) Genomic organization of 
the ovo locus, which encodes three transcripts: ovo-A, ovo-B, and svb. Exons (boxes), introns (straight lines), 
protein coding regions (yellow boxes), and zinc-finger DNA-binding domains (orange boxes) are shown. 
Regions corresponding to the probes for in situ hybridization (purple bars) and the ovo-A– and ovo-B–specific 
region amplified by qRT-PCR analysis (blue and red bars, respectively) are also indicated. Sites where Egfp was 
inserted are indicated by green triangles. The ovoA-Nterm-egfp and ovoB-Nterm-egfp knock-in alleles contain 
the gene in the N-terminal regions of the Ovo-A and Ovo-B proteins, respectively. (b–e) Expression of ovo 
transcripts during embryogenesis. Probes used for in situ hybridization are indicated in (a). Embryos (b and d)  
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Function of maternal Ovo-B is required for both female and male germline development in 
Drosophila. Next, we examined the role of maternal Ovo-B in PGCs. Because oogenesis is completely 
arrested in the ovaries in the absence of ovo-B function14,26, we were unable to obtain embryos lacking mater-
nal ovo-B activity. Furthermore, knockdown of maternal ovo-B by injection of ovo-targeting dsRNA caused 
embryonic lethality due to the lack of epidermal differentiation9. Consequently, we were unable to examine the 
post-embryonic phenotypes caused by knockdown of maternal Ovo-B function. To overcome these problems, 
we used Ovo-A to specifically reduce Ovo-B activity in PGCs; this strategy was based on the prior observation 
that the Ovo-A isoform antagonizes Ovo-B and represses the transcription induced by Ovo-B during oogenesis14.
We conducted two types of Ovo-B knockdown experiments, each involving a different duration of ovo-A 
over-expression. ovo-A expression was induced using the nos-Gal4-VP16 (nos-Gal4) transgene, which expresses 
the transcriptional activator Gal4-VP16 under the control of the germline-specific nos promoter11. In embryos 
derived from females with nos-Gal4, the transcript is maternally supplied and partitioned into PGCs via the 
nos 3′ UTR11. In PGCs, Gal4-VP16 produced from the maternal transcript (maternal nos-Gal4) activated 
UAS-dependent gene expression from stage 11 until at least the end of embryogenesis (Supplementary Fig. S2a). 
By contrast, zygotic expression of nos-Gal4 (zygotic nos-Gal4) activated UAS-dependent gene expression in 
the germline from stage 15 to adulthood (Supplementary Fig. S2b). We induced UASp-Ovo-A expression in the 
germline by maternal and zygotic nos-Gal4 from stage 11 onward, and by maternal nos-Gal4 from stage 11 to at 
least the end of embryogenesis.
Using this system, we first examined germline phenotypes resulting from Ovo-A expression under the control 
of maternal and zygotic nos-Gal4 (mzNG4). Ovo-A–expressing PGCs normally migrated into the gonads, and the 
number of these cells was almost identical to that observed in control embryos (Fig. 2a,b, Supplementary Fig. S3a, b). 
However, the number of Ovo-A–expressing germline cells during larval development was significantly reduced 
relative to controls (Fig. 2a,b, Supplementary Fig. S3a,b); consequently, larvae of both sexes developed into 
agametic adults (Fig. 2f,k, Supplementary Fig. S3e,f). Since maternal Ovo-A activity is required for germline 
development14, we cannot exclude the possibility that the above mentioned germline phenotype is caused by the 
upregulation of Ovo-A rather than the reduction of Ovo-B activity by Ovo-A overexpression. However, we found 
that Ovo-B expression from the ovoamk transgene14 was able to rescue the agametic phenotype caused by Ovo-A 
expression (Fig. 2g,l, Supplementary Fig. S3e,f). This clearly indicates that this phenotype is caused by the reduc-
tion of Ovo-B activity. Therefore, Ovo-B activity is essential for germline development.
A mutation that depletes zygotic Ovo-B activity results in female-specific germline loss after the third instar 
larval stage27,28. This defect obviously differs from that caused by Ovo-A induction by mzNG4, which induces 
germline loss as early as the first instar larval stage in both sexes (Fig. 2a,b, Supplementary Fig. S3a,b). Thus, it 
is reasonable to speculate that maternal, rather than zygotic, Ovo-B is required in germline cells for their devel-
opment in both males and females. To confirm this, we decreased maternal Ovo-B activity by inducing Ovo-A 
in PGCs under the control of maternal nos-Gal4 (mNG4). In females, Ovo-A expression decreased the number 
of germline cells during larval development (Fig. 2c, Supplementary Fig. S3c), resulting in adult sterility (Fig. 2i, 
Supplementary Fig. S3e). This phenotype is consistent with that caused by Ovo-A expression under the control of 
mzNG4 (Fig. 2a,f, Supplementary Fig. S3a,e). By contrast, in males, a subtle but statistically significant decrease 
in the number of germline cells was evident in first-instar larvae (Fig. 2d). However, the number of germline cells 
was restored to control levels after the second instar larval stage (Fig. 2d). These weak phenotypes may result 
from poor expression of Ovo-A in PGCs due to the half dose of maternal nos-Gal4 driver (see legend of Fig. 2). 
Together, these observations suggest that maternal Ovo-B is required in PGCs for normal development in females 
and males.
Maternal Ovo-B activates expression of genes highly enriched in PGCs and suppresses somatic 
gene expression in PGCs. Because Ovo-B protein acts as a transcriptional activator14 and is present in 
nuclei of PGCs during embryogenesis (Fig. 1h–j), we speculated that maternal Ovo-B plays an important role 
in regulating gene expression in PGCs. To investigate this possibility, we compared transcriptomes from Ovo-B 
knockdown (Ovo-B KD) and control PGCs, which were isolated at stage 16 by fluorescence-activated cell sorting 
(FACS) from embryos expressing Ovo-A under the regulation of mzNG4 and control embryos, respectively. In 
our microarray analysis (see Supplementary Materials and Methods), a total of 13,167 genes were expressed in 
and gonads (c and e) were hybridized with a common probe (b and c) and an svb-specific probe (d and e). 
Gonads (c and e) were double-stained for ovo or svb transcript (magenta) and Vasa protein (green), a marker 
for germ plasm and PGCs. The developmental stage of each embryo is shown in lower right. Arrowheads show 
germ plasm and PGCs. Scale bars: 20 μ m. (f) The levels of ovo-A (blue) and ovo-B transcript (red) relative to 
the expression level of ovo-B in st.4 PGCs were determine by qRT-PCR, and plotted against the developmental 
stages of embryogenesis. Means ± SEM of three biological replicates are shown. (g–r) Expression of maternal 
and/or zygotic Ovo protein during embryogenesis. The Ovo-EGFP fusion protein encoded by ovoB-Nterm-egfp 
was detected using an anti-GFP antibody (green). Developmental stages are shown at lower right. Insets show 
close-up images of germ plasm and PGCs. Maternal and zygotic Ovo-EGFP protein was detected in embryos 
derived from females homozygous for ovoB-Nterm-egfp mated with males hemizygous for ovoB-Nterm-egfp 
(g–j). Maternal Ovo-EGFP was detected in embryos with YFP staining, derived from ovoB-Nterm-egfp/FM7c, 
Dfd-GMR-nvYFP females mated with y w males (k–n). Zygotic expression of Ovo-EGFP was detected in only 
female embryos produced from y w females mated with ovoB-Nterm-egfp hemizygous males, since the ovo gene 
is on X chromosome. Scale bars: 20 μ m.
www.nature.com/scientificreports/
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either control PGCs, Ovo-B KD PGCs, or both. Among them, 401 genes were down-regulated and 510 genes were 
up-regulated in Ovo-B KD PGCs (Supplementary Tables S1 and S2).
We performed Gene Ontology (GO) enrichment analysis of the genes down- or up-regulated in Ovo-B KD 
PGCs. Among the genes down-regulated in Ovo-B KD PGCs, no GO category was statistically significantly 
Figure 2. Germline-specific expression of Ovo-A causes germline loss in males and females.  
(a–d) Distribution of the number of Vasa-positive germline cells per gonad of Ovo-A–expressing (red) and 
control (blue) females (a and c) and males (b and d) at embryonic stage 15–16, the first, second, and third instar 
larval stages. Ovo-A was expressed under the control of mzNG4 in progeny derived from nos-Gal4 homozygous 
females mated with UASp-Ovo-A (line#4-2) homozygous males (red bars in a and b). Progeny derived from 
nos-Gal4 homozygous females mated with y w males were used as controls (blue bars in a and b). Furthermore, 
Ovo-A was overexpressed under the control of mNG4 in YFP-positive progeny derived from nos-Gal4/TM6B, 
Dfd-GMR-nvYFP females mated with UASp-Ovo-A (line#4-2) homozygous males (red bars in c and d). YFP-
positive progeny derived from nos-Gal4/TM6B, Dfd-GMR-nvYFP females mated with y w males were used 
as controls (blue bars in c and d). N: the number of gonads observed. Significance of differences relative to 
controls was calculated using Fisher’s exact test (*P < 0.05, **P < 0.01). (e–n) Ovaries (e–i) and testes (j–n) of 
adult progeny derived from nos-Gal4 homozygous females mated with y w males (control-1) (e and j), nos-Gal4 
homozygous females mated with UASp-Ovo-A (line#4-2) homozygous males (f and k), or ovoamk and nos-Gal4 
homozygous females mated with UASp-Ovo-A (line#4-2) homozygous males (g and l); and YFP-positive adult 
progenies derived from nos-Gal4/TM6B, Dfd-GMR-nvYFP females mated with y w males (control-2) (h and m) 
or nos-Gal4/TM6B, Dfd-GMR-nvYFP females mated with UASp-Ovo-A (line#4-2) homozygous males (i and n).  
The ovoamk transgene expresses only Ovo-B under the control of the ovo-B promoter14. Ovaries and testes 
were stained with an anti-Vasa antibody, and the gonads without Vasa signal were categorized as agametic. 
The percentage of agametic gonads is shown at the bottom of each panel. N: the number of gonads examined. 
Significance of difference relative to control-1 (*), Ovo-A o/e by mzNG4 (**), or control-2 (***) was calculated 
by Fischer’s exact test (P < 0.01). Scale bar: 100 μ m.
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enriched (Supplementary Table S3). By contrast, the genes up-regulated in Ovo-B KD PGCs were enriched for 
GO terms associated with development of somatic tissues and organs (q-value < 0.05) (Supplementary Table S4), 
suggesting that Ovo-B represses expression of genes involved in somatic development in PGCs.
This is further supported by our observation that genes expressed mainly in somatic cells (soma-enriched 
genes) were up-regulated in Ovo-B KD PGCs, whereas genes expressed predominantly in PGCs (PGC-enriched 
genes) were down-regulated. We first selected 347 soma-enriched and 145 PGC-enriched genes by comparing the 
transcriptomes of stage-16 PGCs and whole embryos (see Supplementary Materials and Methods). Among 347 
soma-enriched genes, 240 were up-regulated in Ovo-B KD (Fig. 3, Supplementary Table S5). By contrast, among 
145 PGC-enriched genes, 98 were down-regulated in Ovo-B KD PGCs (Fig. 3, Supplementary Table S6).
The above data show that maternal Ovo-B plays an important role in activating expression of PGC-enriched 
genes, as well as in repressing somatic gene expression in PGCs. At least five genes (CG13741, CG14838, 
cup, fal, and piwi), whose expression patterns are annotated only with the anatomical ontology terms “germ 
cells and/or gonads” at stage 13–16 in the BDGP WISH database, were down-regulated in Ovo-B KD PGCs 
(Supplementary Table S1). According to the BDGP database, the four genes other than fal are specifically 
expressed in the germline at stage 13–16, and cup and piwi are both involved in germline development29,30, sug-
gesting that Ovo-B is required to activate the “germline genes” in PGCs.
Three genes, vas, nos, and piwi, are regarded as the germline genes whose expression is commonly observed 
in the germline in multiple animal species1,8. Because probes for detecting endogenous vas and nos transcripts 
were unavailable in the microarrays we used (see Supplementary Materials and Methods), we monitored the 
expression of these genes by qRT-PCR. Our analysis revealed no significant difference in the relative expression 
level of vas between control PGCs [mean ± SEM in log2 (the number of biological replicates: N): 0 ± 0.27 (N = 3)] 
and Ovo-B KD PGCs [0.11 ± 0.14 (N = 3); P > 0.05 (Student’s t-test)]. Similarly, we observed no significant differ-
ence in the relative expression of nos between control PGCs [0 ± 0.08 (N = 3)] and Ovo-B KD PGCs [0.28 ± 0.22 
(N = 3); P > 0.05]. However, injection of dsRNA against ovo into early embryos, which causes more severe defect 
in germline development during embryogenesis than Ovo-A overexpression does31, is able to suppress zygotic 
expression of vas and nos in PGCs9. Furthermore, our present microarray data shows that piwi expression in 
PGCs was also affected by Ovo-B KD (Supplementary Table S1). Based on these findings, we conclude that in 
PGCs, maternal Ovo-B acts as a transcriptional activator for vas, nos, and piwi, which are known to be expressed 
predominantly in the germline of a wide range of animal species. This led us to speculate that ovo plays an evolu-
tionarily conserved role in germline development.
Mouse Ovol2 is required for normal development of PGCs. Mouse has three ovo orthologs, Ovol1, Ovol2, 
and Ovol3; the zinc-finger domains of these genes exhibit significant sequence similarity with Drosophila ovo19,20. 
To investigate whether an ovo ortholog is required for germline development in mouse embryos, we focused on 
Ovol2, which was clearly expressed in early PGCs (Fig. 4a). Ovol2 was expressed in epiblasts of E6.5 embryos, as 
described previously32, and in PGCs isolated from E8.5 embryos; its expression level declined thereafter (Fig. 4a). 
Later, in spermatocytes, expression of Ovol2 protein is detected again33. By contrast, Ovol3 expression was 
Figure 3. Gene expression significantly changed both in the comparison between control and Ovo-B KD 
PGCs, and between PGCs and whole embryos. The x-axis shows the log2 fold change in gene expression 
between PGCs and whole embryos. The y-axis shows the log2 fold change in gene expression between control 
PGCs and Ovo-B KD PGCs. Spots represent genes whose expression levels differed significantly between 
controls and Ovo-B KD PGCs (q-value < 0.05), and between PGCs and whole embryos (q-value < 0.05). When 
multiple microarray probes mapped to a single gene, the average value of the log2 fold change was used. The 
numbers of genes plotted are shown in the corners of each quadrant. Among 145 PGC-enriched genes, which 
are plotted in the right half, more genes were down-regulated than up-regulated by Ovo-B KD [*P < 0.01 
(Fisher’s exact test)]. By contrast, among 347 soma-enriched genes, plotted in the left half, more genes were up-
regulated than down-regulated by Ovo-B KD [**P < 0.01 (Fisher’s exact test)].
www.nature.com/scientificreports/
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undetectable in the PGCs at E8.5, E13.5, and E16.5 (Fig. 4a). We detected Ovol1 expression in PGCs only after 
E13.5 (Fig. 4a), suggesting that this gene plays a minimal role, if any, in the formation and early development of 
PGCs. In males, Ovol1 is required in the germline at later stages for pachytene progression of meiotic spermat-
ogenic cells34. In females, deletion of Ovol1 gene causes reduced fertility, but this is due to somatic defects, i.e., 
structural abnormalities in the urogenital tract34.
To determine whether Ovol2 mutation affects early germline development in mouse embryos, we counted PGCs 
in E8.0–E8.5 embryos, in which Ovol2 is highly expressed (Fig. 4a). Even in the absence of Ovol2 activity, somatic 
development proceeded normally, and the morphology of entire embryo and the neural and mesodermal tissues 
seemed to be intact at E8.032,35. However, significantly fewer PGCs were detected by immunostaining for OCT4, a 
marker for PGCs, in Ovol2 null embryos than in controls (Fig. 4b). For example, we examined embryos with three 
Figure 4. Ovol2 is expressed in mouse PGCs and is required for their development. (a) Relative expression 
levels (log2 scale) of three mouse ovo-like genes (Ovol1, Ovol2, and Ovol3) and three germline markers (Prdm1, 
Ddx4, and Nanos3) were plotted against cell type (ES cells, epiblast, and PGCs) at the indicated embryonic 
stages. Data represent means ± SEM of two biological replicates. *Indicates that the microarray signal was 
detected in only one of two replicates. N.D. Indicates that no signal was detected in either replicate. Successful 
isolation of PGCs using FACS was confirmed by expression of the early PGC maker Prdm1 (E8.5) and the late 
PGC makers Ddx4 and Nanos3 (E13.5 and E16.5). (b) PGCs stained with an anti-Oct4 antibody (red) and 
the nuclei stained with TO-PRO-3 (blue) in mouse E8.0 wild type (Ovol2+/+), heterozygous (Ovol2+/−) or 
homozygous (Ovol2−/−) embryos for Ovol2. Upper panels show fluorescence images, and lower panels show the 
corresponding differential interference contrast (DIC) images. Scale bar: 50 μ m.
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to eight pairs of somites in both control (+ /− ) and null mutant (− /− ) embryos, and found that the null mutants 
contained far fewer OCT4-positive PGCs [number of PGCs ± SEM (number of embryos examined: N): 25.0 ± 7.5 
(N = 6)] than controls [104.5 ± 20.5 (N = 4); P < 0.01 (Student t-test)]. Subsequently, the mutant embryos exhib-
ited lethality by E10.5 due to defects in neural, gut, and heart development, and vascular angiogenesis32,35. 
Consequently, we were unable to follow the developmental fate of PGCs in later-stage mutant embryos.
Evolutionarily conserved role of ovo in germline development in Drosophila and mice. The 
observations described above indicate that, in the absence of Ovol2 activity, the number of PGCs was reduced in 
the embryos with three to eight somites (Fig. 4b). This defect resembled the phenotype observed in Drosophila 
expressing Ovo-A in PGCs (Fig. 2 and Supplementary Fig. S3). Accordingly, we propose that ovo plays an evolu-
tionarily conserved role in germline development in these two animal species.
In mice, BMPs and Wnt are both required to induce PGCs in the epiblast of early embryos4–7. Ovol2 acts 
downstream of the BMP signaling pathway to regulate the cell fate decision between neuroectoderm and mesen-
doderm36. In addition, the Wnt signaling pathway is required to induce Ovol2 in the embryonic stem cells (ESC) 
and the colorectal cancer cells36,37. Therefore, it is reasonable to speculate that Ovol2 is a downstream target for 
BMP and Wnt signaling pathways during PGC induction in epiblast. This is compatible with our data that Ovol2 
expression is upregulated in E8.5 PGCs compared with those in epiblasts and ESCs (Fig. 4a). The transcription 
factors (TFs), Blimp1, Prdm14, and Tfap2c, direct epiblast-like-cells (EpiLCs) into a PGC state and are also key 
downstream components of the BMP and Wnt pathways in the process of PGC induction6,38; therefore, Ovol2 
may act synergistically with these TFs to facilitate PGC formation.
During mouse PGC formation, these TFs activate germline and pluripotent genes, repress somatic genes, and 
reconstitute epigenetic programs38. However, the genetic network regulating PGC formation appears to be diverse 
even among mammals39. For example, reduction of Prdm14 does not affect human PGC formation40, but is suffi-
cient to induce PGC fate in mice38. Furthermore, Prdm14 is not conserved in Drosophila genome (OrthoDB ver.9: 
http://www.orthodb.org), and neither expression nor function of Blimp1 and Tfap2c orthologs has been reported 
in fly PGCs (FlyBase: http://flybase.org). These observations suggest that Blimp1, Prdm14, and Tfap2c do not 
act as a conserved set of TFs directing germline gene expression. By contrast, we show here that in Drosophila, 
maternal Ovo-B activates expression of genes highly enriched in PGCs and conversely suppresses somatic gene 
expression, thereby contributing to determination of “germness”. The ovo gene family is conserved across animal 
species, and encodes transcription factors regulating gene expression in various differentiation processes13. In 
light of the fact that an ovo ortholog is required for PGC formation in mice, we propose that Ovo acts as part of 
an evolutionarily conserved mechanism regulating the genetic network of germline development. In the future, it 
would be of particular interest to identify genes downstream of Ovol2 in mouse PGCs, and to determine whether 
these genes also act downstream of Ovo-B in the Drosophila germline. Our data provide an important first step 
toward elucidation of a mechanism of germline gene regulation common to a wide range of animal species.
Materials and Methods
Drosophila stocks. Nos-Gal4-VP16 (nos-Gal4)11 was used to induce expression of UASp-Ovo-A (line#4-
2, line#7, line#8) in the germline. The ovoamk transgene was used to rescue the agametic phenotype caused by 
Ovo-A overexpression. ovoamk carries the ovo genomic fragment expressing only ovo-B mRNA under the control 
of ovo-B promoter14. To examine the duration of UASp-Ovo-A expression driven by nos-Gal4, P{UASp-GFPS65C-
aTub84B}3 (UASp-GFP) (Bloomington Stock center; #7373) was used. To determine the genotypes of embryos 
derived from females hemizygous for nos-Gal4 and females hemizygous for ovoB-Nterm-egfp (see EGFP knock-in 
mediated by CRISPR/Cas9), nos-Gal4/TM6B, P{Dfd-GMR-nvYFP}4 and ovoB-Nterm-egfp/FM7c, P{Dfd-GMR-
nvYFP}1 were used, respectively. For EGFP knock-in mediated by CRISPR/Cas9, y2 cho2 v1; Sp/CyO, P{nos-
Cas9}2 A (NIG-Fly; CAS-0004) and P{nos-phiC31\int.NLS}X; attP40(II) (NIG-Fly; TBX-0002) were used. Flies 
were maintained on a standard Drosophila medium at 25 °C.
Transgenes. The 5′ - and 3′ -fragments of ovo-A cDNA were amplified from an embryonic cDNA library41. 
Primer pairs ovoA5′ -Fw/ovoA5′ -Rv and ovoA3′ -Fw/ovoA3′ -Rv (Supplementary Table S7) were used for ampli-
fying the 5′ - and 3′ -fragments, respectively. The amplified fragments were ligated using the endogenous Not I 
site and inserted into the KpnI/HindIII sites of pBS-KS nos3′ UTR42. Next, the Kpn I/Xba I fragment containing 
the ovo-A-nos3′ UTR hybrid gene was cloned into pUASp43. Germline transformation was performed using y w 
embryos as recipients. Three independent w+ transformants were mated with y w females to establish a homozy-
gous stock of UASp-Ovo-A.
EGFP knock-in mediated by CRISPR/Cas9. See Supplementary Materials and Methods for details of the 
EGFP knock-in procedure.
mRNA and protein expression analysis. See Supplementary Materials and Methods for details of the 
procedures used for in situ hybridization, quantitative RT-PCR to detect the ovo-A and ovo-B isoforms, immunos-
taining, microarray analysis of Ovo-B KD and control PGCs, microarray analysis of PGCs and whole embryos, 
and quantitative RT-PCR to detect vas and nos.
Mouse ovo-like gene analysis. Microarray analysis of purified mouse PGCs was performed as described44. 
Expression levels of ovo-like genes and other germline markers were extracted from the microarray data. 
Microarray data were deposited in GEO under Accession No. GSE82020.
To count PGCs in mouse embryos, we used null-mutant mice lacking Ovol2 exon 3, which encodes the first 
and second of four zinc-finger domains35. Oct4-positive PGCs in mouse embryos were counted as follows. 
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Embryos of early somite stage (E8.0–8.5) were dissected and immunostained with anti-OCT4 antibody (Santa 
Cruz Biotechnology) as described45. Z-stack confocal images were taken from each embryo using a Zeiss 510, 
and optical slices were analyzed using the ImageJ software. OCT4-positive PGCs were detected, and their X-Y 
positions in each section were recorded. PGCs with the same (or almost the same) X-Y positions were considered 
to be identical, and total PGCs were counted by manual inspection of all optical sections.
All mouse experiments conformed to the Guide for the Care and Use of Laboratory Animals and were 
approved by the Institutional Committee of Laboratory Animal Experimentation of RIKEN BioResource Center.
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